Medical Condition News

RSS

Scientists uncover how bacterium responsible for periodontal disease worsens RA

Does gum disease indicate future joint problems? Although researchers and clinicians have long known about an association between two prevalent chronic inflammatory diseases - periodontal disease and rheumatoid arthritis - the microbiological mechanisms have remained unclear.

13 Sep 2013

Research: Treatment with antioxidants may help reduce behavioral issues linked to NF1

New research in mouse models suggests that treatment with antioxidants may help reduce behavioral issues linked to the genetic nervous system disorder Neurofibromatosis 1 (NF1) and an associated condition called Costello syndrome.

12 Sep 2013

Love Hormone May Play Role In Autism

...

12 Sep 2013

Omeros announces positive data from OMS824 Phase 1 clinical trial

Omeros Corporation today announced positive data from the Company's Phase 1 clinical trial evaluating the pharmacokinetics of OMS824, the lead compound in Omeros' phosphodiesterase 10 program, further supporting that OMS824 can achieve superior target engagement with lesser side effects compared to other PDE10 inhibitors in development.

12 Sep 2013

New study to reduce unwanted side-effects of radiotherapy

Scientists from The University of Manchester are leading a new European study to come up with methods to reduce the unwanted side-effects of radiotherapy and improve cancer treatment.

From The University of Manchester 12 Sep 2013

Merlin and Hippo proteins interact to begin chain of events that control tissue growth

Johns Hopkins researchers have figured out the specific job of a protein long implicated in tumors of the nervous system. Reporting on a new study described in the Sept. 12 issue of the journal Cell, they detail what they call the "matchmaking" activities of a fruit fly protein called Merlin, whose human counterpart, NF2, is a tumor suppressor protein known to cause neurofibromatosis type II when mutated.

12 Sep 2013

Botox Cosmetic receives FDA approval for treatment of crow’s feet lines

The U.S. Food and Drug Administration today approved a new use for Botox Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe lateral canthal lines, known as crow’s feet, in adults. Botox Cosmetic is the only FDA approved drug treatment option for lateral canthal lines.

12 Sep 2013

New Tailored Activity Program to ease troublesome symptoms of dementia

A transformation in the treatment of patients with dementia is quietly taking place at the Lakeside Medical Unit at Johns Hopkins Bayview Medical Center. There, as part of a collaboration with researchers at the Hopkins School of Nursing (JHUSON), clinicians are putting into practice a protocol that can ease the most troublesome symptoms of dementia, not through drugs but with behavior therapy.

12 Sep 2013

IOM’s ‘Delivering High-Quality Cancer Care’ report praised by ASTRO

The American Society for Radiation Oncology (ASTRO) praises the "Delivering High-Quality Cancer Care: Charting a News Course for a System in Crisis" report, issued earlier today by the Institute of Medicine (IOM) of the National Academies.

12 Sep 2013

NIH budget slashing may stall future pain research funding

Multi-faceted pain research discoveries within the last decade are bringing new hope for the estimated 100 million Americans with chronic pain. Unfortunately, translation of these scientific advances into clinical practice could be stalled without sufficient funding for both basic science and clinical pain research, according to the American Pain Society.

12 Sep 2013

Current criteria for ALK positive lung cancer needs to be redefined

A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. The findings suggest that doctors should look closer at borderline or atypical ALK-negative cases, and could widen the population of lung cancer patients offered treatment with crizotinib or other ALK-inhibitor drugs.

12 Sep 2013

Proper precautions may help people with allergies enjoy the beautiful fall weather

As summer comes to a close, kids head back to school and preparation for fall begins, don't' forget to consider fall allergies. An estimated 35 million Americans suffer from allergies, which in the fall begin in late August and peak in September. For those with fall allergies, three triggers typically occur - ragweed, indoor allergens and infections.

12 Sep 2013

Mold Count Exceeds 50,000 threshold in the Midwest, reports Gottlieb Allergy Count

If the unseasonable heat that is blanketing the Midwest doesn't affect area residents, the highest mold count for the 2013 allergy reporting season will. Gottlieb Allergy Count, the official allergy count for the Midwest, reports the mold count today is 85,000, a high for 2013, and well over the 50,000 threshold that signals a dangerous air quality warning.

12 Sep 2013

Research holds promise for developing treatments for retinitis pigmentos

One of the leading causes of inherited blindness in humans, retinitis pigmentosa, is analogous to retinal dystrophies that lead to blindness in dogs. Because of their similarities, identifying gene mutations underlying several types of canine retinal dystrophies has suggested courses for research on RP in humans. These advances are significant for both humans and dogs.

12 Sep 2013

High resolution of U‐SPECT/CT system helps perform kinetic analyses of viral spread in vivo

The ability to visualize and analyze the spread of viral infections in primary and metastatic tumors is an essential component in characterizing the therapeutic efficacy of oncolytic viruses.

12 Sep 2013

Circassia: House dust mite allergy treatment meets primary endpoint in phase II clinical study

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced successful results from a phase II clinical study of its house dust mite allergy treatment (House Dust Mite-Synthetic Peptide Immuno-Regulatory Epitope [HDM-SPIRE] based on Circassia’s ToleroMune technology).

12 Sep 2013

IFHF dedicates new $11 million centre to provide crucial treatment of TBI and PTS to returning veterans

Since September 11, 2001, more than 2.5 million U.S. troops have been deployed to Iraq and Afghanistan, and hundreds of thousands of service members have been diagnosed with traumatic brain injuries, due to IEDs, combat related incidents and training activities.

12 Sep 2013

Family Gene Toolkit may help families communicate about mutation, cancer risk and genetic testing

Actress Angelina Jolie made headlines in May when she revealed she underwent a preventive double mastectomy to reduce her risk of cancer.

12 Sep 2013

Study shows anorexia linked to how cholesterol processes

The largest DNA-sequencing study of anorexia nervosa has linked the eating disorder to variants in a gene coding for an enzyme that regulates cholesterol metabolism. The finding suggests that anorexia could be caused in part by a disruption in the normal processing of cholesterol, which may disrupt mood and eating behavior.

12 Sep 2013

Asthma experts united to tackle Europe's high asthma prevalence and death rates

Asthma experts from across Europe are uniting as part of a new partnership launched this week to tackle Europe's high asthma prevalence and death rates.

12 Sep 2013

Medical Condition News

Scientists uncover how bacterium responsible for periodontal disease worsens RA

Research: Treatment with antioxidants may help reduce behavioral issues linked to NF1

Love Hormone May Play Role In Autism

Omeros announces positive data from OMS824 Phase 1 clinical trial

New study to reduce unwanted side-effects of radiotherapy

Merlin and Hippo proteins interact to begin chain of events that control tissue growth

Botox Cosmetic receives FDA approval for treatment of crow’s feet lines

New Tailored Activity Program to ease troublesome symptoms of dementia

IOM’s ‘Delivering High-Quality Cancer Care’ report praised by ASTRO

NIH budget slashing may stall future pain research funding

Current criteria for ALK positive lung cancer needs to be redefined

Proper precautions may help people with allergies enjoy the beautiful fall weather

Mold Count Exceeds 50,000 threshold in the Midwest, reports Gottlieb Allergy Count

Research holds promise for developing treatments for retinitis pigmentos

High resolution of U‐SPECT/CT system helps perform kinetic analyses of viral spread in vivo

Circassia: House dust mite allergy treatment meets primary endpoint in phase II clinical study

IFHF dedicates new $11 million centre to provide crucial treatment of TBI and PTS to returning veterans

Family Gene Toolkit may help families communicate about mutation, cancer risk and genetic testing

Study shows anorexia linked to how cholesterol processes

Asthma experts united to tackle Europe's high asthma prevalence and death rates

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News